These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29643030)

  • 1. [Screening and verification of key genes in T-cell acute lymphoblastic leukemia].
    Jiang GJ; Chen YH; Guo W; Zhang H; Zou L
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):261-267. PubMed ID: 29643030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
    Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
    BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.
    Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K
    World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis of gene expression profiles in childhood B-precursor acute lymphoblastic leukemia.
    Li J; Zhai X; Wang H; Qian X; Miao H; Zhu X
    Hematology; 2015 Aug; 20(7):377-83. PubMed ID: 25431969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang WX; Pan YY; You CG
    Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
    Li G; Cai L; Zhou L
    Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
    Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L
    Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying endometriosis pathogenesis revealed by bioinformatics analysis of microarray data.
    Ping S; Ma C; Liu P; Yang L; Yang X; Wu Q; Zhao X; Gong B
    Arch Gynecol Obstet; 2016 Apr; 293(4):797-804. PubMed ID: 26354330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis.
    Liu F; Wu Y; Mi Y; Gu L; Sang M; Geng C
    Pathol Res Pract; 2019 Jul; 215(7):152436. PubMed ID: 31076281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding Psoriasis: Integrated Bioinformatics Approach to Understand Hub Genes and Involved Pathways.
    Choudhary S; Pradhan D; Khan NS; Singh H; Thomas G; Jain AK
    Curr Pharm Des; 2020; 26(29):3619-3630. PubMed ID: 32160841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the biomarkers and molecular mechanisms of medulloblastoma based on bioinformatics analysis.
    Yang B; Dai JX; Pan YB; Ma YB; Chu SH
    Oncol Lett; 2019 Jul; 18(1):433-441. PubMed ID: 31289514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
    Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
    Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of β-catenin on differentially expressed genes in multiple myeloma.
    Chen H; Chai W; Li B; Ni M; Zhang GQ; Liu HW; Zhang Z; Chen JY; Zhou YG; Wang Y
    J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):546-552. PubMed ID: 26223925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological processes and pathway changes in isoflurane-induced anesthesia revealed by bioinformatics analysis of gene expression profiles.
    Wang H; Jin Y; Dai J
    J Anesth; 2015 Dec; 29(6):912-9. PubMed ID: 26223573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub Genes and Pathways in Zika Virus Infection Using RNA-Seq Data: A Network-Based Computational Approach.
    Brahma R; Gurumayum S; Naorem LD; Muthaiyan M; Gopal J; Venkatesan A
    Viral Immunol; 2018 May; 31(4):321-332. PubMed ID: 29608426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.